Contact Information

Gilead Sciences Europe Ltd.
(International Headquarters)
2 Roundwood Avenue
South Building
Stockley Park
Uxbridge
Middlesex
UB11 1AF

Phone: 44 (0)208 587 2200
Fax: 44 (0)208 744 6773

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Established in 2005, Gilead's International headquarters is located in Stockley Park in Uxbridge, west of London, England. The office provides centralized support for most of Gilead's operations outside the United States and Canada. The following functions are part of the team providing centralized support for our EU operations: General Management, Finance, Human Resources, Regulatory, Safety, Information Technology, Legal, Medical Affairs and EU Commercial Compliance.

Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2010. The information is correct at the time of writing (March 2011). The information is subject to change and will be updated accordingly.

Grant Recipient	Description of Activity
European AIDS Treatment Group	European community advisory board meeting

HIV Europe	2010 Work programme

World Hepatitis Alliance	World Hepatitis Day Core funding

European Liver Patients Association	Core funding

European AIDS Treatment Group	European community advisory board meeting and travel support

NAM Publications	AIDSMAP Service

European AIDS Treatment Group	'Against all odds' initiative

Stichting Aids Fonds	HIV in Europe

Christian Aid	Bophasiyakhona Educational initiative

European Platform for Patients' Organisations, Science and Industry	2010 Membership fee

Body & Soul	WAIDS Day - fundraising activities

Gemeinnützige Stiftung Sexualitat und Gesundheit (GSSG)	The Twinning Project

European HIV Nurses Association Secretariat	Website development

Cystic Fibrosis Trust	CF Trust meeting

This page is intended for visitors outside of the United States.